Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard LeDuc

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
American Journal of Hypertension|December 20, 2007
Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin IIPatrice C Leclerc, Christophe D Proulx, Guillaume Arguin, et al.
The Journal of Biological Chemistry|March 16, 2006
Cell-surface processing of pro-ADAMTS9 by furinBon-Hun Koo, Jean-Michel Longpré, Robert P T Somerville, et al.
The Journal of Biological Chemistry|November 28, 2001
Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomainsMartin Fugère, Polizois C Limperis, Véronique Beaulieu-Audy, et al.
Organic & Biomolecular Chemistry|November 3, 2016
Design, synthesis, and biological evaluation of CXCR4 ligandsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Plos One|July 4, 2017
Signaling pathways induced by serine proteases to increase intestinal epithelial barrier functionKelcie A Lahey, Natalie J Ronaghan, Judie Shang, et al.
The Journal of Biological Chemistry|May 14, 2005
Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assayMartin Clément, Stéphane S Martin, Marie-Eve Beaulieu, et al.
Biochemical Pharmacology|April 24, 2018
Angiotensin II cyclic analogs as tools to investigate AT<sub>1</sub>R biased signaling mechanismsDavid St-Pierre, Jérôme Cabana, Brian J Holleran, et al.
Journal of Medicinal Chemistry|July 24, 2018
Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)Marc Sousbie, Mélanie Vivancos, Rebecca L Brouillette, et al.
Chemmedchem|December 16, 2011
Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stabilityAlexandre Murza, Alexandre Parent, Elie Besserer-Offroy, et al.
Biochemical Pharmacology|May 12, 2009
Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptorBrian J Holleran, Ivana Domazet, Marie-Eve Beaulieu, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
American Journal of Hypertension|December 20, 2007
Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin IIPatrice C Leclerc, Christophe D Proulx, Guillaume Arguin, et al.
The Journal of Biological Chemistry|March 16, 2006
Cell-surface processing of pro-ADAMTS9 by furinBon-Hun Koo, Jean-Michel Longpré, Robert P T Somerville, et al.
The Journal of Biological Chemistry|November 28, 2001
Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomainsMartin Fugère, Polizois C Limperis, Véronique Beaulieu-Audy, et al.
Organic & Biomolecular Chemistry|November 3, 2016
Design, synthesis, and biological evaluation of CXCR4 ligandsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Plos One|July 4, 2017
Signaling pathways induced by serine proteases to increase intestinal epithelial barrier functionKelcie A Lahey, Natalie J Ronaghan, Judie Shang, et al.
The Journal of Biological Chemistry|May 14, 2005
Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assayMartin Clément, Stéphane S Martin, Marie-Eve Beaulieu, et al.
Biochemical Pharmacology|April 24, 2018
Angiotensin II cyclic analogs as tools to investigate AT<sub>1</sub>R biased signaling mechanismsDavid St-Pierre, Jérôme Cabana, Brian J Holleran, et al.
Journal of Medicinal Chemistry|July 24, 2018
Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13)Marc Sousbie, Mélanie Vivancos, Rebecca L Brouillette, et al.
Chemmedchem|December 16, 2011
Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stabilityAlexandre Murza, Alexandre Parent, Elie Besserer-Offroy, et al.
Biochemical Pharmacology|May 12, 2009
Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptorBrian J Holleran, Ivana Domazet, Marie-Eve Beaulieu, et al.
Pageof 14